-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Speaker

Program: Continuing Conversations with the Speakers
Session: Continuing Conversations with the Speakers on Harnessing T cells in Therapy of Hematologic Malignancy
Sunday, December 6, 2015, 11:15 AM-12:15 PM
W303, Level 3 (Orange County Convention Center)

Crystal L. Mackall, MD

Pediatric Oncology Branch, National Cancer Institute/National Institutes of Health, Bethesda, MD

Disclosures: Mackall: Juno: Patents & Royalties: CD22-CAR . Off Label Use: cyclophosphamide.

See more of: Continuing Conversations with the Speakers on Harnessing T cells in Therapy of Hematologic Malignancy
See more of: Continuing Conversations with the Speakers
<< Previous Presentation | Next Presentation